Xcovery

We are dedicated to advancing next gen targeted therapeutics as promising new treatments to improve lives of cancer patients.

[Xcovery @Xcovery]

Today we announced our participation in the #NCI Formulary! #clinicaltrials #LCSM #lungcancer #cancer

https://t.co/Od5LzmSaer

[Xcovery @Xcovery]

Check out our collaboration with the new NCI formulary!

https://t.co/7jDUydV2HU

#CancerMoonshot

[Global Pharma News @pharma_global]

NCI launches new drug formulary to help expedite use of agents in clinical studies - News… https://t.co/AwusYmGtm8

[Krystyna @krystyna_kk]

.@MrPug94 new #clinicaltrial #targetedtherapy available to any patient locally https://t.co/ZXK0WhzZ3C ..50%under 40 NSCLC PTS = ALK+

[Krystyna @krystyna_kk]

.@RPHPresearch @SeaBrinkley Heres another video to get you motivated. lets work together and change lives https://t.co/Qme9yrmset

[Krystyna @krystyna_kk]

50%of ALK #lungcancer pts are nonsmokers under 40 #targetedtrial for researching Docs with newly diagnosed patients https://t.co/skaIHZK99N https://t.co/Nfcpft1jmK

[Optimal Research @OptimalResearch]

It's Monday &Holly is here to take on the #whiplungcancer challenge!
Its lungcancerawareness month.Let's #fightcancer together. #lungcancer

[Krystyna @krystyna_kk]

..@Xcovery ALK+ #LungCancer is a killer of young health non smokers. Good luck on your new product #bethedifference https://t.co/ZXK0WhRAsc

[Xcovery @Xcovery]

Check out the new site https://t.co/FSCAC4JFkH created by @LungAssociation and @TheALCF, let's help #beatlungcancer! #LCAM #LCSM

[Xcovery @Xcovery]

Check out our video for #whiplungcancer! #LCSM Help us spread awareness! https://t.co/Ge8UosVjpB

[Xcovery @Xcovery]

We accepted the #whiplungcancer challenge! We nominate @novellaclinical, @VanderbiltU and Betta Pharmaceuticals! https://t.co/Ge8UosVjpB

[Krystyna @krystyna_kk]

I took #whiplungcancer challenge! I nominate @Xcovery @StupidCancer @MDTweetThyself and all my followers! Let's spread awareness together. https://t.co/IE58rWlzYf

[GO2 for Lung Cancer @GO2forLungCancr]

Today is #WorldLungCancerDay. Help us raise awareness by sharing this image with your community. #WLCD16 #LCSM

[Xcovery @Xcovery]

Take a look at our website https://t.co/DnMTaekbq0 to find out more about what we are up to! #lungcancer #LCSM #Oncology

[Xcovery @Xcovery]

We Announced the Initiation of our Phase 3 Trial of X-396 in ALK+ Non-Small Cell Lung Cancer. Read the release here:https://t.co/EXso2ywsVL

[Xcovery @Xcovery]

Check out the latest news, insights, and opportunities from Xcovery. https://t.co/aW4x5iMmU7

[BioWorld @BioWorld]

Xcovery goes head-to-head against Xalkori, seeks to prove superiority in phase III NSCLC trial

[Xcovery @Xcovery]

We presented data from expansion cohort in the ongoing eXalt2 study of ensartinib in patients w/ ALK+ NSCLC #ASCO16
https://t.co/Igjqwe371s

[Xcovery @Xcovery]

Xcovery presented results from ongoing clinical trial of X-396 in patients with ALK+ #NSCLC at AACR Annual Meeting https://t.co/3C2vls2Hpe